###
Both CAP and ASCP use the AMA to turn pathology’s concerns into positions of organized medicine—and to prevent organized medicine from adopting policies they consider harmful. Your example captures a central function: representation includes advancing proposals, rewriting them, and sometimes securing their referral or defeat.
The distinction is principally whom each organization represents and where it concentrates its institutional effort, rather than one having a relationship with AMA and the other lacking one. ASCP’s formal name is the American Society for Clinical Pathology.
| Dimension | CAP–AMA relationship | ASCP–AMA relationship |
|---|---|---|
| Organizational constituency | Strongly centered on physician pathologists and the practice of pathology. | Represents physician pathologists and the broader laboratory professional workforce. |
| Institutional strengths brought to AMA | Practice economics, physician responsibilities, laboratory quality, accreditation, and technical expertise in coding and valuation. | Laboratory education, certification, workforce, diagnostic practice, and physician pathology expertise. |
| House of Delegates participation | Has its own delegation and has repeatedly led coordinated pathology advocacy through the Pathology Section Council. | Has its own delegation and participates in the same council; it can originate and champion its own resolutions. |
| Typical emphasis—not an exclusive division | Protecting pathology practice, payment, scope, and its place in the health system. | Advancing pathology and the laboratory team, including workforce sustainability and access to diagnostic services. |
These differences reflect their stated missions and documented activities. ASCP also advocates on payment; CAP also advocates on workforce and education. Treating CAP as “political” and ASCP as merely “educational” would be inaccurate. CAP
At the HOD, they are participants in a coalition, not branches of AMA. Each retains its own governance and positions. The Pathology Section Council provides a forum for coordinating testimony, resolving differences, and presenting a common position with other pathology societies. CAP’s leadership of that coalition does not make ASCP subordinate to CAP. Overlapping memberships and experienced delegates also mean that personal relationships can cross organizational lines. CAP
Your point about slowing or stopping unwanted initiatives has a particularly direct documented example: in November 2023, CAP reported that it worked with the Pathology Section Council to defeat a resolution concerning the RUC, which CAP believed would disrupt the process and harm pathology’s participation. That is CAP’s characterization of the proposal [no further detail at this link], but the defensive purpose of its involvement is explicit. College of American Pathologists
The available tactics include negotiating amendments, providing reference-committee testimony, building support among other specialties, and seeking referral for further consideration instead of immediate adoption. Neither society has a unilateral veto. Influence depends on persuading the broader House and knowing its procedures. ama-assn.org
ASCP uses the same institution for substantive advocacy. Two examples illustrate its reach:
- LDT regulation, 2023: ASCP secured adoption of a resolution asking AMA to urge FDA to extend the proposed rule’s comment period. Its delegates explained potential effects on access to testing.
- Laboratory workforce, 2026: ASCP originated a resolution on laboratory professional shortages, obtained Pathology Section Council support—including CAP—and secured AMA adoption. This brought the needs of nonphysician laboratory professionals into the physician organization’s policy agenda. ascp.org
For your reimbursement work, a second relationship matters alongside the HOD: CPT and the RUC. CAP maintains an organized apparatus for participating in those processes, including CPT and RUC advisers and its Economic Affairs Committee. For example, CAP describes leading work on CAR-T coding and RVU recommendations. These are distinct decision processes: passing an HOD resolution does not itself create a CPT code or establish its Medicare payment. CAP
My institutional reading is that CAP approaches AMA especially as a place to protect and shape the professional and economic position of pathology; ASCP approaches it as a place to advance pathology and the wider laboratory enterprise. Both benefit when AMA lends its broader political authority to their concerns. AMA, in return, gains specialty expertise, engaged physician members, and support for collective advocacy.
For a genomics client, that means support from one society is valuable but does not establish a unified pathology position—or assure an AMA outcome. The practical questions are which society owns the initiative, whether the pathology coalition agrees, and whether the actual decision lies in the HOD, CPT, RUC, or outside AMA altogether.
